"Aged" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 65 through 79 years of age. For a person older than 79 years, AGED, 80 AND OVER is available.
Descriptor ID |
D000368
|
MeSH Number(s) |
M01.060.116.100
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged".
Below are MeSH descriptors whose meaning is more specific than "Aged".
This graph shows the total number of publications written about "Aged" by people in this website by year, and whether "Aged" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 35 | 35 |
1996 | 0 | 37 | 37 |
1997 | 0 | 55 | 55 |
1998 | 0 | 47 | 47 |
1999 | 0 | 19 | 19 |
2000 | 0 | 56 | 56 |
2001 | 0 | 70 | 70 |
2002 | 0 | 96 | 96 |
2003 | 0 | 84 | 84 |
2004 | 2 | 85 | 87 |
2005 | 0 | 99 | 99 |
2006 | 0 | 96 | 96 |
2007 | 0 | 116 | 116 |
2008 | 2 | 119 | 121 |
2009 | 0 | 138 | 138 |
2010 | 0 | 156 | 156 |
2011 | 0 | 180 | 180 |
2012 | 0 | 205 | 205 |
2013 | 0 | 190 | 190 |
2014 | 0 | 184 | 184 |
2015 | 1 | 195 | 196 |
2016 | 0 | 257 | 257 |
2017 | 0 | 276 | 276 |
2018 | 0 | 227 | 227 |
2019 | 0 | 264 | 264 |
2020 | 0 | 226 | 226 |
2021 | 0 | 161 | 161 |
2022 | 0 | 68 | 68 |
2023 | 0 | 36 | 36 |
2024 | 0 | 107 | 107 |
2025 | 0 | 12 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aged" by people in Profiles.
-
A phase 1 study of the combination of BH3-mimetic, navitoclax, and mTORC1/2 inhibitor, vistusertib, in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2025 Feb 25; 95(1):37.
-
Update on safety and feasibility of the combination of pembrolizumab and pelvic chemoradiation in locally advanced cervical cancer. Cancer. 2025 Feb 15; 131(4):e35757.
-
Classifying COVID-19 hospitalizations in epidemiology cohort studies: The C4R study. PLoS One. 2025; 20(2):e0316198.
-
Types of electronic nicotine delivery systems (ENDS) used by people of different age and smoking status groups: results from a US nationally representative survey. BMJ Open. 2025 Feb 07; 15(2):e087775.
-
Depression and Incident Hypertension: The Strong Heart Family Study. Prev Chronic Dis. 2025 Jan 16; 22:E06.
-
National survey of financial burden and experience among patients with cancer and autoimmune disease receiving charitable copay assistance. Cancer. 2025 Jan 15; 131(2):e35721.
-
Clinical and Genomic Features of Androgen Indifferent Prostate Cancer. Int J Mol Sci. 2025 Jan 15; 26(2).
-
First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer. J Immunother Cancer. 2025 Jan 11; 13(1).
-
Financial Toxicity in Older Adults With Cancer and Their Caregivers. JCO Oncol Pract. 2025 Jan; 21(1):92-99.
-
Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial. Nat Commun. 2025 Jan 09; 16(1):553.